-
EP1893592
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1893592
| EP1893592 - OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.03.2010 Database last updated on 02.11.2024 | Most recent event Tooltip | 19.03.2010 | Application deemed to be withdrawn | published on 21.04.2010 [2010/16] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2008/10] | Inventor(s) | 01 /
BUTLIN, Roger John AstraZeneca R & D Alderley Alderley Park Macclesfield Cheshire SK10 4TG / GB | 02 /
GREEN, Clive Philip, AstraZeneca R & D Alderley Alderley Park Macclesfield Cheshire SK10 4TG / GB | 03 /
MCCOULI, William AstraZeneca R & D Alderley Alderley Park Macclesfield Cheshire SK10 4TG / GB | [2008/10] | Application number, filing date | 06744121.2 | 06.06.2006 | [2008/10] | WO2006GB02067 | Priority number, date | GB20050011851 | 11.06.2005 Original published format: GB 0511851 | GB20050018924 | 16.09.2005 Original published format: GB 0518924 | [2008/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2006134317 | Date: | 21.12.2006 | Language: | EN | [2006/51] | Type: | A1 Application with search report | No.: | EP1893592 | Date: | 05.03.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.12.2006 takes the place of the publication of the European patent application. | [2008/10] | Search report(s) | International search report - published on: | EP | 21.12.2006 | Classification | IPC: | C07D271/10, C07D413/12, A61K31/535, A61P3/00 | [2008/10] | CPC: |
C07D271/113 (EP,KR,US);
A61P1/04 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P15/08 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P19/10 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/08 (EP);
A61P3/10 (EP);
A61P3/12 (EP);
A61P31/10 (EP);
A61P31/18 (EP);
A61P37/02 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/10] | Extension states | RS | Not yet paid | Title | German: | OXADIAZOLDERIVATE ALS DGAT-INHIBITOREN | [2008/10] | English: | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | [2008/10] | French: | DÉRIVÉS D OXADIAZOLE EN TANT QU INHIBITEURS DE LA DIACYLGLYCÉROL ACYLTRANSFÉRASE (DGAT) | [2008/10] | Entry into regional phase | 11.01.2008 | National basic fee paid | 11.01.2008 | Designation fee(s) paid | 11.01.2008 | Examination fee paid | Examination procedure | 11.01.2008 | Examination requested [2008/10] | 19.05.2009 | Despatch of a communication from the examining division (Time limit: M04) | 30.09.2009 | Application deemed to be withdrawn, date of legal effect [2010/16] | 17.11.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/16] | Fees paid | Renewal fee | 28.03.2008 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.06.2009 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2004007455 (AVENTIS PHARMA GMBH [DE]) [A] 1-13* the whole document *; | [DA]WO2004047755 (TULARIK INC [US], et al) [DA] 1-13 * the whole document *; | [DA]WO2004100881 (BAYER PHARMACEUTICALS CORP [US], et al) [DA] 1-13 * the whole document * |